Summit plc (formerly VASTox Ltd)
Summit is a drug discovery company with an innovative technology platform called Seglins for the discovery of new medicines, a portfolio of partner funded drug programmes and a commercial strategy of signing multiple early-stage deals.
Summit’s internal research is currently focussed in the high value therapy areas of type II diabetes and infectious diseases and the company will further exploit the technology’s wider potential by establishing strategic alliances.